Cormorant Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Cormorant Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-194,274	Closed	-$2.23M	–	72
2018 Q4	$2.23M	Sell	194,274 -5,726	-3%	-$71.1K	0.18%	64
2018 Q3	$3.39M	Sell	200,000 -182,192	-48%	-$2.77M	0.22%	55
2018 Q2	$5.43M	Hold	382,192	–	–	0.4%	48
2018 Q1	$7.26M	Sell	382,192 -17,808	-4%	-$381K	0.54%	34
2017 Q4	$6.56M	Hold	400,000	–	–	0.69%	33
2017 Q3	$6M	Hold	400,000	–	–	1.06%	29
2017 Q2	$3.52M	Sell	400,000 -200,000	-33%	-$1.28M	0.58%	45
2017 Q1	$3.12M	Sell	600,000 -50,000	-8%	-$201K	0.45%	49
2016 Q4	$1.98M	Sell	650,000 -752,331	-54%	-$2.74M	0.27%	61
2016 Q3	$6.49M	Hold	1,402,331	–	–	0.72%	43
2016 Q2	$8.12M	Buy	+1,402,331	New	+$8.94M	1.15%	31
2015 Q4	–	Sell	-361,000	Closed	-$2.04M	–	90
2015 Q3	$2.04M	Hold	361,000	–	–	0.33%	60
2015 Q2	$4M	Sell	361,000 -81,000	-18%	-$1.04M	0.53%	45
2015 Q1	$6.93M	Sell	442,000 -58,000	-12%	-$897K	1.07%	29
2014 Q4	$7.61M	Hold	500,000	–	–	1.17%	25
2014 Q3	$5.39M	Hold	500,000	–	–	1.11%	27
2014 Q2	$7.63M	Sell	500,000 -100,000	-17%	-$1.44M	2.02%	16
2014 Q1	$10.8M	Buy	600,000 +433,800	+261%	+$8.36M	2.49%	16
2013 Q4	$2.31M	Buy	+166,200	New	+$1.91M	0.67%	25

Other funds holding SGMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cormorant Asset Management's SGMO Position: Q1 2019 in Review

Cormorant Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2019, closing a stake of 194,274 shares — an estimated $2.23M sold.

Cormorant Asset Management first reported a position in SGMO in Q4 2013 and held it in 19 quarters. The position peaked at $10.8M in Q1 2014. 187 funds tracked by Wall St. Rank hold SGMO as of Q1 2019.

Cormorant Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2019 after selling out during the quarter.
Cormorant Asset Management sold 194,274 SANGAMO THERAPEUTICS INC shares in Q1 2019, an estimated $2.23M.
Cormorant Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2013 and held it in 19 quarters.
Cormorant Asset Management's SANGAMO THERAPEUTICS INC position peaked at $10.8M in Q1 2014.
187 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2019.

Based on Cormorant Asset Management's 13F filing for Q1 2019, filed 15 May 2019.